Before your first dose, make sure youre comfortable with the injection process, as it is self-administered
The compound is endogenously released at sites of tissue injury through breakdown of SPARC and type I collagen meaning its biology connects directly to repair signaling rather than acting as an exogenous-only tool compound
Mechanism of Action: Triple Receptor Agonist Retatrutide is a synthetic peptide that activates three key metabolic receptors: GLP-1 (Glucagon-Like Peptide-1) Enhances insulin secretion, suppresses appetite, delays gastric emptying GIP (Glucose-Dependent Insulinotropic Polypeptide) Boosts insulin response, improves insulin sensitivity, may support lipid metabolism Glucagon Receptor (GCGR) Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development
In case of exacerbation of atopic eczema due to aeroallergens, rehabilitation in aeroallergen-poor climates (sea level or high altitude mountains) has been recommended (Borelli, 1981)
This product is pharmaceutical grade and may be used in food, diet supplementation or as a pharmaceutical therapy additive product